Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

Deliverables

Dissemination and public engagement Report 4

Dissemination and public engagement reports

Dissemination and public engagement Report 1

Dissemination and public engagement reports

Dissemination and public engagement Report 2

Dissemination and public engagement reports

Dissemination and public engagement Report 3

Dissemination and public engagement reports

Report on GLIOTRAIN conference

GLIOTRAIN Web presence

Website, Twitter, Facebook Page construction

Publications

Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM

Author(s): Viktorija Juric, Heiko Düssmann, Martine L. M. Lamfers, Jochen H. M. Prehn, Markus Rehm, Brona M. Murphy
Published in: Cells, Issue 10/5, 2021, Page(s) 1182, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells10051182

The influence of methylation status on a stochastic model of MGMT dynamics in glioblastoma: Phenotypic selection can occur with and without a downshift in promoter methylation status

Author(s): Ayoub Lasri, Marc Sturrock
Published in: Journal of Theoretical Biology, Issue 521, 2021, Page(s) 110662, ISSN 0022-5193
Publisher: Academic Press
DOI: 10.1016/j.jtbi.2021.110662

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

Author(s): Anna Golebiewska, Ann-Christin Hau, Anaïs Oudin, Daniel Stieber, Yahaya A. Yabo, Virginie Baus, Vanessa Barthelemy, Eliane Klein, Sébastien Bougnaud, Olivier Keunen, May Wantz, Alessandro Michelucci, Virginie Neirinckx, Arnaud Muller, Tony Kaoma, Petr V. Nazarov, Francisco Azuaje, Alfonso De Falco, Ben Flies, Lorraine Richart, Suresh Poovathingal, Thais Arns, Kamil Grzyb, Andreas Mock, Christel
Published in: Acta Neuropathologica, Issue 140/6, 2020, Page(s) 919-949, ISSN 0001-6322
Publisher: Springer Verlag
DOI: 10.1007/s00401-020-02226-7

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions

Author(s): Viktorija Juric, Brona Murphy
Published in: Cancer Drug Resistance, Issue 3, 2020, Page(s) 48-62, ISSN 2578-532X
Publisher: OAE Publishing Inc
DOI: 10.20517/cdr.2019.105

Linking hyperosmotic stress and apoptotic sensitivity.

Author(s): Daniela Stöhr; Markus Rehm
Published in: The FEBS Journal, Issue 288/6, 2021, Page(s) 1800-1803, ISSN 1742-464X
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/febs.15520

Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation

Author(s): Viktorija Juric, Lance Hudson, Joanna Fay, Cathy E. Richards, Hanne Jahns, Maïté Verreault, Franck Bielle, Ahmed Idbaih, Martine L. M. Lamfers, Ann M. Hopkins, Markus Rehm, Brona M. Murphy
Published in: Cell Death & Disease, Issue 12/8, 2021, Page(s) 763, ISSN 2041-4889
Publisher: Nature Publishing Group
DOI: 10.1038/s41419-021-04050-7

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors

Author(s): Anaïs Oudin, Virginie Baus, Vanessa Barthelemy, Carina Fabian, Eliane Klein, Monika Dieterle, May Wantz, Ann-Christin Hau, Claire Dording, Amandine Bernard, Alessandro Michelucci, Yahaya A. Yabo, Georgia Kanli, Olivier Keunen, Rolf Bjerkvig, Simone P. Niclou, Anna Golebiewska
Published in: STAR Protocols, Issue 2/2, 2021, Page(s) 100534, ISSN 2666-1667
Publisher: Cell Press
DOI: 10.1016/j.xpro.2021.100534

Master regulators associated with poor prognosis in glioblastoma multiforme

Author(s): M P Kalya, T Beisbarth, A Kel
Published in: Biomeditsinskaya khimiya, Issue 67/3, 2021, Page(s) 201-212, ISSN 2310-6972
Publisher: Institute of Biomedical Chemistry
DOI: 10.18097/pbmc20216703201

New hints towards a precision medicine strategy for IDH wild-type glioblastoma

Author(s): K. White, K. Connor, J. Clerkin, B.M. Murphy, M. Salvucci, A.C. O'Farrell, M. Rehm, D. O'Brien, J.H.M. Prehn, S.P. Niclou, M.L.M. Lamfers, M. Verreault, A. Idbaih, R. Verhaak, A. Golebiewska, A.T. Byrne
Published in: Annals of Oncology, Issue 31/12, 2020, Page(s) 1679-1692, ISSN 0923-7534
Publisher: Oxford University Press
DOI: 10.1016/j.annonc.2020.08.2336

Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics

Author(s): Ayoub Lasri, Viktorija Juric, Maité Verreault, Franck Bielle, Ahmed Idbaih, Alexander Kel, Brona Murphy, Marc Sturrock
Published in: Royal Society Open Science, Issue 7/7, 2020, Page(s) 191243, ISSN 2054-5703
Publisher: Royal Society Publishing
DOI: 10.1098/rsos.191243

IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme

Author(s): Manasa Kalya, Alexander Kel, Darius Wlochowitz, Edgar Wingender, Tim Beißbarth
Published in: Frontiers in Genetics, Issue 12, 2021, ISSN 1664-8021
Publisher: Frontiers Media
DOI: 10.3389/fgene.2021.670240

Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism

Author(s): Frank A. Lincoln, Dirke Imig, Chiara Boccellato, Viktorija Juric, Janis Noonan, Roland E. Kontermann, Frank Allgöwer, Brona M. Murphy, Markus Rehm
Published in: Cell Death & Disease, Issue 9/11, 2018, Page(s) 1112, ISSN 2041-4889
Publisher: Nature Publishing Group
DOI: 10.1038/s41419-018-1160-2

Bax retrotranslocation potentiates Bcl-xL’s antiapoptotic activity and is essential for switch-like transitions between MOMP competency and resistance

Author(s): Annika Hantusch; Kushal K. Das; Ana J. García-Sáez; Thomas Brunner; Markus Rehm
Published in: Cell Death & Disease, Issue 9 (4), 2018, Page(s) 430, ISSN 2041-4889
Publisher: Nature Publishing Group
DOI: 10.1038/s41419-018-0464-6

RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells

Author(s): Bo Lou, Kate Connor, Kieron Sweeney, Ian S. Miller, Alice O’Farrell, Eduardo Ruiz-Hernandez, David M. Murray, Garry P. Duffy, Alan Wolfe, Enrico Mastrobattista, Annette T. Byrne, Wim E. Hennink
Published in: Drug Delivery and Translational Research, Issue 9/3, 2019, Page(s) 679-693, ISSN 2190-393X
Publisher: Springer Pub. Co.,
DOI: 10.1007/s13346-019-00637-y

Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents

Author(s): Ian S. Miller, Liam P. Shiels, Emer Conroy, Kate Connor, Patrick Dicker, William M. Gallagher, Norma O’ Donovan, Robert S. Kerbel, John Crown, Annette T. Byrne
Published in: Scientific Reports, Issue 9/1, 2019, Page(s) 9204, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-019-45444-0

Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies

Author(s): Kate Connor, David W. Murray, Monika A. Jarzabek, Nhan L. Tran, Kieron White, Patrick Dicker, Kieron J. Sweeney, Philip J. O’Halloran, Brian MacCarthy, Liam P. Shiels, Francesca Lodi, Diether Lambrechts, Jann N. Sarkaria, Raymond M. Schiffelers, Marc Symons, Annette T. Byrne
Published in: Cancers, Issue 12/12, 2020, Page(s) 3531, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12123531

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma

Author(s): Janis J. Noonan, Monika Jarzabek, Frank A. Lincoln, Brenton L. Cavanagh, Arhona R. Pariag, Viktorija Juric, Leonie S. Young, Keith L. Ligon, Hanne Jahns, Daniella Zheleva, Jochen H. M. Prehn, Markus Rehm, Annette T. Byrne, Brona M. Murphy
Published in: Cancers, Issue 11/12, 2019, Page(s) 2005, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers11122005

Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist

Author(s): Chiara Boccellato, Emily Kolbe, Nathalie Peters, Viktorija Juric, Gavin Fullstone, Maïté Verreault, Ahmed Idbaih, Martine L. M. Lamfers, Brona M. Murphy, Markus Rehm
Published in: Cell Death & Disease, Issue 12/7, 2021, ISSN 2041-4889
Publisher: Nature Publishing Group
DOI: 10.1038/s41419-021-03927-x

Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures

Author(s): Cassandra Verheul, Ioannis Ntafoulis, Trisha V Kers, Youri Hoogstrate, Pier G Mastroberardino, Sander Barnhoorn, César Payán-Gómez, Romain Tching Chi Yen, Eduard A Struys, Stijn L W Koolen, Clemens M F Dirven, Sieger Leenstra, Pim J French, Martine L M Lamfers
Published in: Neuro-Oncology Advances, Issue 3/1, 2021, ISSN 2632-2498
Publisher: Oxford Academic
DOI: 10.1093/noajnl/vdab103

System-based approaches as prognostic tools for glioblastoma

Author(s): Manuela Salvucci, Zaitun Zakaria, Steven Carberry, Amanda Tivnan, Volker Seifert, Donat Kögel, Brona M. Murphy, Jochen H. M. Prehn
Published in: BMC Cancer, Issue 19/1, 2019, Page(s) 1092, ISSN 1471-2407
Publisher: BioMed Central
DOI: 10.1186/s12885-019-6280-2

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Author(s): Ana Rita Pombo Antunes, Isabelle Scheyltjens, Francesca Lodi, Julie Messiaen, Asier Antoranz, Johnny Duerinck, Daliya Kancheva, Liesbet Martens, Karen De Vlaminck, Hannah Van Hove, Signe Schmidt Kjølner Hansen, Francesca Maria Bosisio, Koen Van der Borght, Steven De Vleeschouwer, Raf Sciot, Luc Bouwens, Michiel Verfaillie, Niels Vandamme, Roosmarijn E. Vandenbroucke, Olivier De Wever, Yvan Saeys,
Published in: Nature Neuroscience, Issue 24/4, 2021, Page(s) 595-610, ISSN 1097-6256
Publisher: Nature Publishing Group
DOI: 10.1038/s41593-020-00789-y

Deliverables

Publications

Share this page

Download